Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
intraductal carcinoma noninfiltrating
MeSH D002285 - intraductal carcinoma noninfiltrating
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000230:
Adenocarcinoma
24 Companies
3 Drugs
$
Success rate
D000071960:
Breast carcinoma in situ
0 Companies
0 Drugs
Success rate
D018299:
And medullary lobular ductal neoplasms
0 Companies
0 Drugs
Success rate
D002285:
Intraductal carcinoma noninfiltrating
0 Companies
0 Drugs
Success rate
D010144:
Mammary paget's disease
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
42
%
5/12
Phase 2
6
%
1/16
Phase 3
0
%
0/1
Approved:
0
Overall Success rate:
0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use